Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Thioredoxin-interacting protein suppresses bladder carcinogenesis.

Nishizawa K, Nishiyama H, Matsui Y, Kobayashi T, Saito R, Kotani H, Masutani H, Oishi S, Toda Y, Fujii N, Yodoi J, Ogawa O.

Carcinogenesis. 2011 Oct;32(10):1459-66. doi: 10.1093/carcin/bgr137. Epub 2011 Jul 18.

2.

Fluorescent imaging of high-grade bladder cancer using a specific antagonist for chemokine receptor CXCR4.

Nishizawa K, Nishiyama H, Oishi S, Tanahara N, Kotani H, Mikami Y, Toda Y, Evans BJ, Peiper SC, Saito R, Watanabe J, Fujii N, Ogawa O.

Int J Cancer. 2010 Sep 1;127(5):1180-7. doi: 10.1002/ijc.25145.

3.

Null mutation for macrophage migration inhibitory factor (MIF) is associated with less aggressive bladder cancer in mice.

Taylor JA 3rd, Kuchel GA, Hegde P, Voznesensky OS, Claffey K, Tsimikas J, Leng L, Bucala R, Pilbeam C.

BMC Cancer. 2007 Jul 24;7:135.

4.

Inhibition of the SDF-1alpha-CXCR4 axis by the CXCR4 antagonist AMD3100 suppresses the migration of cultured cells from ATL patients and murine lymphoblastoid cells from HTLV-I Tax transgenic mice.

Kawaguchi A, Orba Y, Kimura T, Iha H, Ogata M, Tsuji T, Ainai A, Sata T, Okamoto T, Hall WW, Sawa H, Hasegawa H.

Blood. 2009 Oct 1;114(14):2961-8. doi: 10.1182/blood-2008-11-189308. Epub 2009 Aug 5.

5.

Susceptibility of p27 kip1 knockout mice to urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine may not simply be due to enhanced proliferation.

Hikosaka A, Ogawa K, Sugiura S, Asamoto M, Takeshita F, Sato SY, Nakanishi M, Kohri K, Shirai T.

Int J Cancer. 2008 Mar 15;122(6):1222-8.

6.

Involvement of matrix metalloproteinase-9 in stromal cell-derived factor-1/CXCR4 pathway of lung cancer metastasis.

Tang CH, Tan TW, Fu WM, Yang RS.

Carcinogenesis. 2008 Jan;29(1):35-43. Epub 2007 Oct 4.

7.

Chemopreventive effects of silymarin and silibinin on N-butyl-N-(4-hydroxybutyl) nitrosamine induced urinary bladder carcinogenesis in male ICR mice.

Tyagi A, Raina K, Singh RP, Gu M, Agarwal C, Harrison G, Glode LM, Agarwal R.

Mol Cancer Ther. 2007 Dec;6(12 Pt 1):3248-55.

8.

CXCR4-mediated Stat3 activation is essential for CXCL12-induced cell invasion in bladder cancer.

Shen HB, Gu ZQ, Jian K, Qi J.

Tumour Biol. 2013 Jun;34(3):1839-45. doi: 10.1007/s13277-013-0725-z. Epub 2013 Mar 23.

PMID:
23526079
9.

Expression and function of CXCR4 in human salivary gland cancers.

Uchida D, Kuribayashi N, Kinouchi M, Ohe G, Tamatani T, Nagai H, Miyamoto Y.

Clin Exp Metastasis. 2013 Feb;30(2):133-42. doi: 10.1007/s10585-012-9518-9. Epub 2012 Jul 31.

PMID:
22847686
10.

Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats.

Grubbs CJ, Lubet RA, Koki AT, Leahy KM, Masferrer JL, Steele VE, Kelloff GJ, Hill DL, Seibert K.

Cancer Res. 2000 Oct 15;60(20):5599-602.

11.

High susceptibility of p53(+/-) knockout mice in N-butyl-N-(4-hydroxybutyl)nitrosamine urinary bladder carcinogenesis and lack of frequent mutation in residual allele.

Ozaki K, Sukata T, Yamamoto S, Uwagawa S, Seki T, Kawasaki H, Yoshitake A, Wanibuchi H, Koide A, Mori Y, Fukushima S.

Cancer Res. 1998 Sep 1;58(17):3806-11.

12.

Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model.

Kitaori T, Ito H, Schwarz EM, Tsutsumi R, Yoshitomi H, Oishi S, Nakano M, Fujii N, Nagasawa T, Nakamura T.

Arthritis Rheum. 2009 Mar;60(3):813-23. doi: 10.1002/art.24330.

13.

Dihydrotestosterone upregulates the expression of epidermal growth factor receptor and ERBB2 in androgen receptor-positive bladder cancer cells.

Zheng Y, Izumi K, Yao JL, Miyamoto H.

Endocr Relat Cancer. 2011 Jul 4;18(4):451-64. doi: 10.1530/ERC-11-0010. Print 2011 Aug.

14.

Involvement of SDF-1alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma.

Kajiyama H, Shibata K, Terauchi M, Ino K, Nawa A, Kikkawa F.

Int J Cancer. 2008 Jan 1;122(1):91-9.

15.

PAUF functions in the metastasis of human pancreatic cancer cells and upregulates CXCR4 expression.

Lee Y, Kim SJ, Park HD, Park EH, Huang SM, Jeon SB, Kim JM, Lim DS, Koh SS.

Oncogene. 2010 Jan 7;29(1):56-67. doi: 10.1038/onc.2009.298. Epub 2009 Sep 28.

PMID:
19784070
16.

[Effect of chemokine stromal cell derived factor-1 and its receptor CXCR4 on the peritoneal carcinometastasis of gastric cancer].

Ding YL, Zhang JL, Tang SF, Fu QY, Li ZT.

Zhonghua Yi Xue Za Zhi. 2008 Jan 15;88(3):202-5. Chinese.

PMID:
18361822
17.

Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway.

Sauvé K, Lepage J, Sanchez M, Heveker N, Tremblay A.

Cancer Res. 2009 Jul 15;69(14):5793-800. doi: 10.1158/0008-5472.CAN-08-4924. Epub 2009 Jul 7.

18.
19.

Fez1/Lzts1-deficient mice are more susceptible to N-butyl-N-(4-hydroxybutil) nitrosamine (BBN) carcinogenesis.

Baffa R, Fassan M, Sevignani C, Vecchione A, Ishii H, Giarnieri E, Iozzo RV, Gomella LG, Croce CM.

Carcinogenesis. 2008 Apr;29(4):846-8. doi: 10.1093/carcin/bgn006. Epub 2008 Jan 12.

20.

The CXCR4 antagonist AMD3100 suppresses hypoxia-mediated growth hormone production in GH3 rat pituitary adenoma cells.

Yoshida D, Koketshu K, Nomura R, Teramoto A.

J Neurooncol. 2010 Oct;100(1):51-64. doi: 10.1007/s11060-010-0152-6. Epub 2010 Mar 23.

PMID:
20309720
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk